CMV gB Activators
Chemical compounds that serve as activators would, therefore, be involved in modulating this process. The activation could be direct, through binding to the gB protein and inducing a conformational change that facilitates its function, or indirect, by influencing the cellular or viral pathways that regulate gB expression or activity. CMV gB (1-M-12) Activators comprise a spectrum of chemical compounds that indirectly facilitate the functional activity of CMV gB (1-M-12), a pivotal protein in the cytomegalovirus entry and fusion process with host cell membranes. Compounds such as Forskolin and Dibutyryl cAMP operate through the elevation of intracellular cAMP, leading to the activation of protein kinase A (PKA). PKA is known to phosphorylate substrates that may include the CMV gB (1-M-12) or proteins closely interacting with it, thus potentiating its role in membrane fusion crucial for viral entry. Similarly, Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent protein kinases that may directly phosphorylate CMV gB (1-M-12), enhancing its fusogenic capacity.
This is echoed by the action of cyclic ADP-ribose and nitric oxide donors like SNAP, which through modulation of cGMP pathways, can also lead to the activation of kinases that may phosphorylate and thereby augment the activity of CMV gB (1-M-12). Furthermore, lipid-derived molecules such as Sphingosine-1-phosphate and Arachidonic acid, as well as cholesterol, can influence membrane dynamics and signaling pathways intricately tied to the fusion process mediated by CMV gB (1-M-12). Additionally, structural biology approaches, including X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, have provided detailed insights into the three-dimensional structure of the CMV gB-activator complex. These structural studies contribute to a deeper understanding of the molecular basis of CMV gB activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). Activation of PKC can lead to the phosphorylation of viral glycoproteins, which could potentially enhance CMV gB-mediated membrane fusion with host cells. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a lipid signaling molecule that can activate sphingosine-1-phosphate receptors, leading to cytoskeletal rearrangements. This can facilitate closer apposition of the viral envelope to the host cell membrane, potentially enhancing CMV gB's ability to mediate fusion. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
YC-1 activates sGC, leading to increased levels of cyclic GMP (cGMP). Elevated cGMP can enhance CMV gB fusion activity by modulating intracellular signaling pathways that affect the cytoskeleton and membrane dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. This activation can lead to downstream effects that enhance CMV gB-mediated membrane fusion through PKA-dependent phosphorylation processes. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a precursor to eicosanoids, arachidonic acid can modulate inflammatory responses and alter cell membrane fluidity, potentially enhancing CMV gB's capacity to mediate viral entry into host cells. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Niacin can influence the lipid composition of membranes by acting as a precursor for NAD+/NADP+, which are coenzymes in lipid metabolism. Altered lipid composition may enhance CMV gB's fusion with host cell membranes. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid can integrate into cell membranes, increasing fluidity, and potentially facilitating the membrane fusion events that CMV gB mediates during viral entry. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophores like A23187 increase intracellular calcium concentration, which can activate calcium-dependent signaling pathways, potentially enhancing CMV gB function in membrane fusion. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium, which can modify the membrane fusion process mediated by CMV gB through calcium-dependent signaling pathways. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
cAMP analogs mimic the action of cAMP and can activate PKA, which may phosphorylate proteins that regulate membrane fusion, potentially enhancing the fusogenic activity of CMV gB. | ||||||